메뉴 건너뛰기
Tumor Diagnostik und Therapie
Volumn 23, Issue 4, 2002, Pages 135-136
Diagnosis and treatment of plasma cell leukemia;Diagnostik und therapie der plasmazell-leukämie
Author keywords

Diagnosis; Incidence; Plasma cell leukemia; Treatment
Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUDARABINE; MELPHALAN; PREDNISONE; VINCRISTINE;
EID: 17944387198     PISSN: 0722219X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-33857     Document Type: Review
Times cited : (2)
References (10)
  • 1
    • 0028897160 scopus 로고
    • Leukemias, myeloma and other lymphoreticular neoplasms
    • Hernandez JA, Land KJ, Mc Kenna RW. Leukemias, myeloma and other lymphoreticular neoplasms. Cancer 1994; 75 (Suppl): 381-394
    • (1994) Cancer , vol.75 , Issue.SUPPL. , pp. 381-394
    • Hernandez, J.A.1    Land, K.J.2    Mc Kenna, R.W.3
  • 2
    • 0033380205 scopus 로고    scopus 로고
    • Clinical significance of the translocation (11; 14) (q 13; q 32) in multiple myeloma
    • Fonseca R, Hoyer JD, Aguayo P, et al. Clinical significance of the translocation (11; 14) (q 13; q 32) in multiple myeloma. Leuk Lymphoma 1999; 35: 599-605
    • (1999) Leuk Lymphoma , vol.35 , pp. 599-605
    • Fonseca, R.1    Hoyer, J.D.2    Aguayo, P.3
  • 3
    • 0344142354 scopus 로고    scopus 로고
    • Primary plasma cell leukemia: Clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics
    • Garcia-Sanz R, Orfao A, Gonzalez M, et al. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood 1999; 93: 1032-1037
    • (1999) Blood , vol.93 , pp. 1032-1037
    • Garcia-Sanz, R.1    Orfao, A.2    Gonzalez, M.3
  • 4
    • 17344371597 scopus 로고    scopus 로고
    • The absence of CD 56 on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma
    • Pellat-Deceunynck C, Barille S, Jego G, et al. The absence of CD 56 on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma. Leukemia 1998; 12: 1977-1982
    • (1998) Leukemia , vol.12 , pp. 1977-1982
    • Pellat-Deceunynck, C.1    Barille, S.2    Jego, G.3
  • 5
    • 0030694727 scopus 로고    scopus 로고
    • Characterization of p 16 (INK4A) expression in multiple myeloma and plasma cell leukemia
    • Urashima M, Teoh G, Ogata A, et al. Characterization of p 16 (INK4A) expression in multiple myeloma and plasma cell leukemia. Clin Cancer Res 1997; 3: 2173-2179
    • (1997) Clin Cancer Res , vol.3 , pp. 2173-2179
    • Urashima, M.1    Teoh, G.2    Ogata, A.3
  • 6
    • 0030046122 scopus 로고    scopus 로고
    • Non-random chromosomal rearrangements and their implications in clinical features and out-come in multiple myeloma and plasma cell leukemia
    • Taniwaki M, Nishida K, Ueda, Takashima T. Non-random chromosomal rearrangements and their implications in clinical features and out-come in multiple myeloma and plasma cell leukemia. Leuk Lymphoma 1996; 21: 25-30
    • (1996) Leuk Lymphoma , vol.21 , pp. 25-30
    • Taniwaki, M.1    Nishida, K.2    Ueda3    Takashima, T.4
  • 7
    • 0033396918 scopus 로고    scopus 로고
    • Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia
    • Blade J, Kyle RA. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. Hematol Oncol Clin North Am 1999; 13: 1259-1279
    • (1999) Hematol Oncol Clin North Am , vol.13 , pp. 1259-1279
    • Blade, J.1    Kyle, R.A.2
  • 8
    • 0023634218 scopus 로고
    • Plasma cell leukemia: An evaluation of response to therapy
    • Noel P, Kyle RA. Plasma cell leukemia: an evaluation of response to therapy. Amer J Med 1987; 83: 1062-1068
    • (1987) Amer J Med , vol.83 , pp. 1062-1068
    • Noel, P.1    Kyle, R.A.2
  • 9
    • 0029024154 scopus 로고
    • Fludarabine and plasma cell leukemia
    • Björkholm M, Ösby E. Fludarabine and plasma cell leukemia. Eur J Haematol 1995; 54: 334-335
    • (1995) Eur J Haematol , vol.54 , pp. 334-335
    • Björkholm, M.1    Ösby, E.2
  • 10
    • 0032807767 scopus 로고    scopus 로고
    • Long-term survival in primary plasma cell leukemia after therapy with VAD, autologous blood stem cell transplantation and interferon-alpha
    • Panizo C, Rifon J, Rodriguez-Wilhelmi P, et al. Long-term survival in primary plasma cell leukemia after therapy with VAD, autologous blood stem cell transplantation and interferon-alpha. Acta Heamatol 1999; 101: 193-196
    • (1999) Acta Heamatol , vol.101 , pp. 193-196
    • Panizo, C.1    Rifon, J.2    Rodriguez-Wilhelmi, P.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.